Watchlist Price Alert

Ensysce Biosciences Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

2.60

-0.37 (-12.46%)

At close: May 02, 2025, 3:59 PM

2.60

-0.14%

After-hours: May 02, 2025, 05:52 PM EDT

Ensysce Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-7.99M	-10.63M	-24.21M	-29.15M	-160.88K	365.95K	-1.34M	-31.19K
Depreciation & Amortization	n/a	n/a	n/a	151.00	201.00	201.00	n/a	n/a
Stock-Based Compensation	110.72B	879.16K	1.07M	121.76K	178.68K	6.04M	n/a	n/a
Other Working Capital	-272.32K	107.95K	2.84M	120K	-998.72K	2.46M	126.38K	-213.47K
Other Non-Cash Items	-7,613.4B	-85.79K	-233.42K	7.49M	997.46K	8.17M	-317.21K	-231.1K
Deferred Income Tax	n/a	n/a	n/a	14.6M	-2.45M	-1.76K	1.76K	n/a
Change in Working Capital	-851.25K	-947.08K	5.48M	-1.3M	185.1K	2.46M	273.13K	-101.5K
Operating Cash Flow	-7,502.7B	-10.78M	-17.89M	-8.24M	-1.25M	10.99M	-1.24M	-251.83K
Capital Expenditures	n/a	2.00	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	4.5K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-566.29K	n/a	-200M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	4.5K	n/a	183.4M	11.85M	838.59K	n/a
Investing Cash Flow	n/a	n/a	4.5K	n/a	183.4M	-566.29K	838.59K	-200M
Debt Repayment	-485.19K	605.43K	6.13M	13.91M	1.1M	400K	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-11.58M	n/a	n/a
Dividend Paid	-290M	n/a	-913.2K	-803.14B	n/a	n/a	n/a	n/a
Other Financial Acitivies	9,881.5B	-899.55K	3.55M	-225.68K	20.00	166.27K	n/a	n/a
Financial Cash Flow	9,881.2B	8.76M	8.77M	20.31M	1.1M	-11.03M	-32K	202.34M
Net Cash Flow	2,378.5B	-2.02M	-9.12M	12.07M	-147.32K	-597.25K	-431.68K	2.09M
Free Cash Flow	-7,502.7B	-10.78M	-17.89M	-8.24M	-1.25M	10.99M	-1.24M	-251.83K